Concerns include: How long children will need to stay on the medications What happens when they stop taking them Potential side effects over many years of use Whether medication could replace healthy lifestyle changes Common side effects of GLP-1 drugs can include nausea, vomiting, diarrhea, and stomach-related issues
In 2009, Novo Nordisk's Liraglutide (Victoza) was approved by the EMA and in January 2010 by the FDA for the treatment of type 2 diabetes
We first demonstrated that GLP-1 or the GLP-1R agonist exendin-4 suppressed GABAR-mediated currents (GABA currents) in isolated rat retinal GCs through GLP-1R activation
Safety and Precautions Who Should Avoid GLP-1 Medications
Its everything you need all in one place. Related:
Retatrutide is a triple-hormone receptor agonist designed to target GLP-1, GIP, and glucagon receptors simultaneously